BREZALYNX Trademark

Trademark Overview

On Thursday, February 15, 2018, a trademark application was filed for BREZALYNX with the United States Patent and Trademark Office. The USPTO has given the BREZALYNX trademark a serial number of 87799153. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by AstraZeneca AB. The BREZALYNX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of respiratory diseases and disorders
brezalynx

General Information

Serial Number87799153
Word MarkBREZALYNX
Filing DateThursday, February 15, 2018
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5870901
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in the treatment of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, February 19, 2018NEW APPLICATION ENTERED
Monday, May 14, 2018ASSIGNED TO EXAMINER
Thursday, January 17, 2019SOU EXTENSION 1 FILED
Thursday, January 17, 2019SOU EXTENSION 1 GRANTED
Thursday, January 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 30, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 19, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 19, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 17, 2019SOU TEAS EXTENSION RECEIVED
Friday, August 2, 2019TEAS DELETE 1(B) BASIS RECEIVED
Saturday, January 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2019NOTICE OF ALLOWANCE CANCELLED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 28, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

brezalynx diseases disorders respiratory treatment preparations substances pharmaceutical